The role of Fas in autoimmune diabetes

被引:453
作者
Chervonsky, AV
Wang, Y
Wong, FS
Visintin, I
Flavell, RA
Janeway, CA
Matis, LA
机构
[1] HOWARD HUGHES MED INST,NEW HAVEN,CT 06510
[2] ALEXION PHARMACEUT,NEW HAVEN,CT 06511
关键词
D O I
10.1016/S0092-8674(00)80178-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunologically privileged sites express Fas ligand (FasL), which protects them from attack by activated T cells that express Fas and die upon contact with FasL. In an attempt to protect nonobese diabetic mice (NOD) from autoimmune diabetes, we made FasL transgenic NOD mice using the beta cell-specific rat insulin-1 promoter. Surprisingly, these transgenic mice showed heightened sensitivity to diabetogenic T cells, which was due to self-destruction of beta cells upon T cell-mediated induction of Fas. Fas-negative NODlpr/lpr animals were resistant to diabetogenic T cells and to spontaneous diabetes. Thus, induction of Fas expression on beta cells and their subsequent destruction constitutes the main pathogenic mechanism in autoimmune diabetes.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 47 条
[21]   XENOGENEIC MONOCLONAL ANTIBODIES TO MOUSE LYMPHOID DIFFERENTIATION ANTIGENS [J].
LEDBETTER, JA ;
HERZENBERG, LA .
IMMUNOLOGICAL REVIEWS, 1979, 47 :63-90
[22]   CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes [J].
Lenschow, DJ ;
Herold, KC ;
Rhee, L ;
Patel, B ;
Koons, A ;
Qin, HY ;
Fuchs, E ;
Singh, B ;
Thompson, CB ;
Bluestone, JA .
IMMUNITY, 1996, 5 (03) :285-293
[23]   DIABETES AND TOLERANCE IN TRANSGENIC MICE EXPRESSING CLASS-II MHC MOLECULES IN PANCREATIC BETA-CELLS [J].
LO, D ;
BURKLY, LC ;
WIDERA, G ;
COWING, C ;
FLAVELL, RA ;
PALMITER, RD ;
BRINSTER, RL .
CELL, 1988, 53 (01) :159-168
[24]   THE MOUSE FAS-LIGAND GENE IS MUTATED IN GLD MICE AND IS PART OF A TNF FAMILY GENE-CLUSTER [J].
LYNCH, DH ;
WATSON, ML ;
ALDERSON, MR ;
BAUM, PR ;
MILLER, RE ;
TOUGH, T ;
GIBSON, M ;
DAVISSMITH, T ;
SMITH, CA ;
HUNTER, K ;
BHAT, D ;
DIN, W ;
GOODWIN, RG ;
SELDIN, MF .
IMMUNITY, 1994, 1 (02) :131-136
[25]  
Murphy E. D., 1978, Genetic control of autoimmune disease. Proceedings of the workshop on the genetic control of autoimmune disease held in Bloomfield Hills, Michigan, USA, on July 10-12, 1978., P207
[26]  
NAGATA M, 1994, J IMMUNOL, V152, P2042
[27]   THE FAS DEATH FACTOR [J].
NAGATA, S ;
GOLSTEIN, P .
SCIENCE, 1995, 267 (5203) :1449-1456
[28]   LETHAL EFFECT OF THE ANTI-FAS ANTIBODY IN MICE [J].
OGASAWARA, J ;
WATANABEFUKUNAGA, R ;
ADACHI, M ;
MATSUZAWA, A ;
KASUGAI, T ;
KITAMURA, Y ;
ITOH, N ;
SUDA, T ;
NAGATA, S .
NATURE, 1993, 364 (6440) :806-809
[29]   DIFFERENTIAL ABILITY OF T(H)1 AND T(H)2 T-CELLS TO EXPRESS FAS LIGAND AND TO UNDERGO ACTIVATION-INDUCED CELL [J].
RAMSDELL, F ;
SEAMAN, MS ;
MILLER, RE ;
PICHA, KS ;
KENNEDY, MK ;
LYNCH, DH .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (10) :1545-1553
[30]   MUTATIONS IN FAS ASSOCIATED WITH HUMAN LYMPHOPROLIFERATIVE SYNDROME AND AUTOIMMUNITY [J].
RIEUXLAUCAT, F ;
LEDEIST, F ;
HIVROZ, C ;
ROBERTS, IAG ;
DEBATIN, KM ;
FISCHER, A ;
DEVILLARTAY, JP .
SCIENCE, 1995, 268 (5215) :1347-1349